May 17, 2016

Biomarker-Driven Trials: How Laboratory Insight Can Enhance Clinical Trial Design and Optimize Drug Development

Presented at the 2015 Outsourcing in Clinical Trials New England Conference, this presentation will review current trends and challenges in biomarker-driven drug development; highlight how your laboratory partner can provide support for successful trial execution from early to late-phase; and review key case studies demonstrating the benefits provided through pharma/laboratory collaboration.

Download the presentation to learn how biomarkers in clinical trials are the new frontier of drug development.

Related Services:
Gene expression for keeping pace with immuno-oncology breakthroughs and biomarker identification

When and how to use gene expression profiling

Precision medicine: Shifting from one drug for all patients to personalized genomics-based therapeutic options

Planning and implementing biomarker testing for immuno-oncology trials

Exploring the challenges with the diverse clinical biomarker requirements

Read More